Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
A pharmaceutical industry purchasing manager's perspective
August 22, 2005
By: Martin H.
“Hi, Jay, this is Julie Smith, VP of business development for Acme Pharma Services. You may remember that we met at the recent pharmaceuticals conference and trade show in New York. Jay, we’d like to talk with you about becoming one of your preferred suppliers for…” These calls are not uncommon, and their implied message seems to be that there are certain criteria that can be “checked off” to elevate a contractor to some mystical status or list intended to assure future business. In reality, the “list” may or may not exist. Getting placed on such a list, even if it does exist, is not usually the result of meeting some easily defined objective criteria. More likely, it is the consequence of long-standing, demonstrated performance, as well as the desire on the part of both the contractor and the sponsor to invest in the relationship. This article examines those key factors that can influence a buyer to consider a contractor as “preferred,” and the implications of such status for both the customer and the supplier.
What is a “Preferred” Supplier? Among the definitions given for “preference” is “the act, fact or principle of giving advantages to some over others” and “priority in the right to demand and receive satisfaction of an obligation.”(1) If I, as a buyer, have a preferred supplier, it implies that I give that contractor advantages over other suppliers – most likely in the form of business. The concept of being a preferred contractor may have different connotations, depending on one’s responsibilities. To a salesperson, it probably increases the likelihood of receiving more of a certain customer’s business than the salesperson’s competitors—that is, the customer is giving this contractor advantages versus other suppliers. To the buyer’s internal customers, the end users of the product or service being sourced, a preferred contractor may simply be a firm with which the buyer would like to do business, as opposed to a firm with which it has had bad experiences, or perhaps no experience at all. Such situations reflect a certain comfort level with incumbency, whether or not such incumbency is in the customer’s best interests. The buyer-seller relationship may, without any negative experiences to influence it, gain its own momentum. Changing this momentum (that is, changing to new suppliers) requires organizational energy that may not be readily available. Thus many incumbents over time become de facto preferred suppliers. As a purchasing professional, I take a different view of the preferred contractor classification. Such status should be conferred intentionally and thoughtfully. If such a relationship offers the contractor the advantage of more business, then it is fair to ask, “What are the advantages offered to the customer?” The real benefit to the buyer is not in having preferred suppliers. It is in having suppliers for whom the buyer is a preferred customer—that is, a customer whom the contractor will favor over other customers. In other words, the contractor will not treat all customers the same; the contractor will take care of a preferred customer before taking care of another customer. This type of preference is proven only over time and thus most preferred customer-contractor relationships evolve through incumbency. For either party to consider the other “preferred,” each has to be willing to invest time and energy into developing the relationship. Over the long run it is the quality of the relationship that is really going to result in better value for both parties. Because it will require an investment, the decision to have a preferred contractor (or customer) in the first place—regardless of which company it is—should be driven by business requirements. If the supply base and market conditions can provide the buyer with the quality and value that is needed at the place and time it is needed, there may be no incentive to have “preferred” suppliers for a particular product or service. However, if such an analysis leads to the conclusion that having one or more preferred suppliers is appropriate, then which firms get selected? The major reason for choosing to develop and have preferred suppliers is the extent to which they can provide the customer with a competitive advantage in the customer’s marketplace. In this context, “competitive advantage” means the ability to provide the customer with a unique product or service, or a degree of quality or value that is otherwise not available to the customer’s competitors, or is not available from other suppliers. Michael Porter discussed this at length more than 15 years ago: “Competitive advantage grows fundamentally out of value a firm is able to create for its buyers that exceeds the firm’s cost of creating it. Value is what buyers are willing to pay, and superior value stems from offering lower prices than competitors for equivalent benefits or providing unique benefits that more than offset a higher price. There are two basic types of competitive advantage: cost leadership and differentiation.”(2) Many suppliers still do not understand this concept. A frequent question I ask while evaluating pharmaceutical contract research organizations (CROs) is “What competitive advantage will you offer me as a customer?” Very often the question is met with blank stares, or a response is offered that addresses how the contractor will maintain the confidentiality of my work. In these cases I respond that I consider safeguarding confidentiality to be a prerequisite of doing business, and that what I’m asking about is what the contractor can offer me that is not readily available to my competition. The ensuing facial expressions often reflect utter disbelief! Methods of offering competitive advantage can take many forms. While most favorable commercial terms may come to mind first, note that Mr. Porter alludes to customer willingness to pay higher prices for unique benefits. Examples might include access to the supplier’s most talented staff, first right of refusal on plant capacity, favorable intellectual property licensing or ownership rights, prototyping new technology, in-country presence or expertise or a supplier’s willingness to forego working on another customer’s projects for the same pharmaceutical indication. Does this mean that all suppliers have to offer competitive advantages or preferences to certain customers? Not at all—the decision to do so or not is a strategic choice. A business plan to treat all customers the same is honorable and can especially benefit smaller customers. However, unless such a contractor truly stands out from its own competition in terms of uniqueness or value, its status of incumbency is always at risk of another contractor coming along who is willing to offer certain customers preferential treatment.
What is a Buyer Looking for In a Preferred Supplier? Developing a preferred contractor may be as simple as a joint decision to further the relationship with an incumbent supplier, or it can be one step in a lengthy and complex contractor selection process. In either case, the buyer desires an excellent contractor in a collaborative relationship. We should try to address what this “excellence” looks like. Within the pharmaceutical industry, internal customer requirements are generally quality, timeliness and value (where “value” is a cost-factored analysis of the previous two factors), usually in that order. A preferred contractor would address all three of these aspects (quality, timeliness and value) continually. The attributes discussed below intentionally constitute a very high standard. A preferred contractor will have systems in place to achieve and then exceed this bar (i.e., continually setting new standards of excellence). Throughout this discussion, note the emphasis on systemic approaches to the work, as opposed to intermittent, or person-based, approaches.
What “Excellence” Looks Like The critical outcomes of quality, timeliness and value can be measured in three areas that cover the full range of customer-contractor activities: Project (or Work) Execution: This is the underlying reason for the existence of the working relationship in the first place—what was outsourced and who was hired to deliver the work. In addition to all technical aspects related to the scope of work (e.g., patient recruitment, scale-up of a custom synthesis, GMP packaging and labeling), it includes all required deliverables such as product, analyses, reports and so on. Work Administration/Management: This area deals with the non-scope-related activities associated with executing the work. Generally this includes activities such as communications, budget management and order/ shipping/billing activities. These are the types of activities that, if not well-managed, can get in the way of the work and distract customer/scientist time away from the customer’s important core work processes. Commercial Arrangements: This area deals with the commercial terms and conditions associated with agreeing to do the work. From a work process perspective, the usual intent is to negotiate and gain agreement to these early in the relationship, and then let the work proceed without having to address these concerns much if at all, during the course of the agreement. Let’s examine the most significant attributes for each critical outcome in each of these areas:
Quality
Timeliness
Alignment
Resources
Communications
Getting Started Entering into a preferred customer-contractor relationship needs to be a data-based business decision on the part of both parties. It should not be taken lightly, as the level of startup and ongoing commitment that is required can be substantial. Customers will often make the mistake of assuming that since they are outsourcing to an expert in the field, they can forget about having to manage that particular piece of their business. What they are overlooking is the importance and value of interpersonal relationships in accomplishing work, particularly the complex work of pharmaceutical development. While it may take less time to manage the day-to-day business that is being handed over to an external supplier, the effort required to understand and gain alignment with expectations and objectives, coupled with that required to build strong relationships, can far exceed that required for in-house work. Both the customer and contractor must ask each other and themselves, “What do we expect to get out of a ‘preferred’ relationship, and what are we willing to invest to get it?” This is not the same as buying something over the counter at the local hardware store, or buying a used car. In these cases, it may be fair to assume that, because I am paying a certain sum of money, I have a right to expect a well-defined product or service. This is easy in one-off consumer transactions. In preferred business relationships however, both parties may have significantly greater expectations of the other that are largely information-dependent. So if the customer expects to get information, giving information up front may be critical. The need and willingness to share information leads to the issue of trust. Before entering a preferred relationship, both the customer and contractor need to be willing to share information with each other that they might not normally share with another customer or supplier. A customer attitude of “do it this way because I said so and I’m paying for it” is a power play that does not yield effective long-term results. Jordan Lewis addresses this in detail in his book, Trusted Partners—How Companies Build Mutual Trust and Win Together: “…[C]ompanies that wield purchasing power over their suppliers, like modern Napoleons, get hostility in return. They also receive much less value from those suppliers—in terms of inferior costs, quality, technology, cycle time and more—than do firms that develop trust with them.”(3)
Issues Facing Industry The dynamics of the pharmaceutical industry can both promote and hinder the development of preferred relationships. Favoring such arrangements are the long lead times associated with clinical studies and development, which result in firms working closely together over extended periods. The frequent, almost universal requirements for confidential disclosure agreements can promote open discussions about the customer’s business direction and what is necessary for both the customer and contractor to be successful. Working with the same contractor over multiple projects may lead to a de facto preferred relationship even though the desire for such a relationship may never have been expressed openly. However, in such situations, parties should periodically ask themselves, “Am I in this relationship because it’s right for my business today, or simply because I ended up here over time?” In the latter case, although it may be awkward and time-consuming to leave a mediocre incumbent relationship and pursue better value, it may be the right long-term business decision. There are also adverse factors within the industry. Turnover of personnel on both sides of the customer-contractor fence, including both technical leaders as well as business development personnel, is a problem. It gets in the way of developing strong interpersonal relationships that lead to collaborative customer-contractor interactions. It can also lead to buyers moving business from one firm to another to stay with a person who has provided good service in the past. This is why it is important for suppliers to make sure that they meet the customer’s critical outcomes with systemic approaches versus key person-dependent methods. Another issue facing suppliers is being flexible enough to deal with a “dyed-in-the-wool” big pharma manufacturer that wants everything done a certain way, as opposed to a “virtual” pharma company that is pursuing its first lead compound and does not know how to get started. The benefits to a customer for having a preferred contractor that can deliver the critical outcomes of quality, timeliness and value to the degree discussed earlier are significant. The contractor that wants to be “preferred” needs to consider if it can afford to make this level of commitment to one or more customers. Is it in a position to offer a competitive advantage to a customer? Can it do so without compromising its own strategy or other business relationships? The buyer willing to consider a preferred contractor needs to ensure that its internal customers really understand the commitment they need to make to develop and maintain the relationship. The investment required by the customer and the supplier, in terms of time and effort, may be larger than either expected. In return, such performance may result in a long-standing profitable business relationship for both.
References (1) Webster’s Ninth New Collegiate Dictionary, Merriam-Webster Inc., Springfield, MA, 1991. (2) Competitive Advantage. Porter, Michael E., Free Press, 1985, p. 3. (3) Trusted Partners. Lewis, Jordan D., Free Press, 1999, p. xv.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !